愛朋醫療(300753.SZ):盛宇黑科已減持164.292萬股 擬繼續清倉減持不超1.77%股份
格隆匯 7 月 23日丨愛朋醫療(300753.SZ)公佈,公司於近日收到股東上海盛宇黑科創業投資中心(有限合夥)(“盛宇黑科”或“股東”)出具的《關於減持股份實施情況的告知函》和《關於股份減持計劃告知函》,盛宇黑科此前披露的減持計劃目前已實施完成,且其出具了新的減持計劃。
截至2020年7月23日,盛宇黑科合計減持股份164.292萬股,其中轉增前減持145.69萬股,轉增後減持186,020股,其餘20.683萬股在減持區間內不再減持,上述減持計劃已實施完成。截至公告日,盛宇黑科持有公司股份185.901萬股,佔公司現總股本的1.77%。
公司於2020年7月23日收到了盛宇黑科出具的《關於股份減持計劃告知函》,計劃以集中競價交易或大宗交易方式減持公司股份,減持數量不超過185.901萬股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.